BioNTech SE (BNTX) Net Income (2018 - 2026)
BioNTech SE (BNTX) reported Net Income of -$954.07 million for Q2 2026, compared with -$437.62 million a year earlier.
Powered by 
Analysis
BioNTech SE (BNTX) Net Income (2018 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, BioNTech SE's Net Income came in at -$1.97 billion; for FY2025, it was -$1.32 billion.
- By year, Net Income came in at -$710.94 million in FY2024, $1 billion in FY2023 (-89.6%), $9.63 billion in FY2022 (-18.3%) and $11.77 billion in FY2021.
- The Q2 2026 figure ranks as the lowest quarterly Net Income in data going back to Q3 2018.
- The high point for year-over-year Net Income in five years was Q4 2021 (growth of 728.0%); the low point was Q3 2023 (a decline of 90.3%).
- Per Business Quant data, the three quarters before Q2 2026 came in at -$622.72 million (Q1 2026), -$355.03 million (Q4 2025) and -$33.55 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 5.53 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 3.62 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | -1.34 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 3.26 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 2.51 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 2.38 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -10.50 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -237.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.10 Bn |
| 10 | BioNTech SE | 24.86 Bn | -34.51 Bn | 10.00 Mn | -954.07 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -954.07 Mn |
| Mar 31, 2026 | -622.72 Mn |
| Dec 31, 2025 | -355.03 Mn |
| Sep 30, 2025 | -33.55 Mn |
| Jun 30, 2025 | -437.62 Mn |
| Mar 31, 2025 | -437.37 Mn |
| Dec 31, 2024 | 277.30 Mn |
| Sep 30, 2024 | 217.56 Mn |
| Jun 30, 2024 | -869.91 Mn |
| Mar 31, 2024 | -342.31 Mn |
| Dec 31, 2023 | 492.67 Mn |
| Sep 30, 2023 | 174.83 Mn |
| Jun 30, 2023 | -207.33 Mn |
| Mar 31, 2023 | 539.03 Mn |
| Dec 31, 2022 | 2.32 Bn |
| Sep 30, 2022 | 1.80 Bn |
| Jun 30, 2022 | 1.78 Bn |
| Mar 31, 2022 | 4.15 Bn |
| Dec 31, 2021 | 3.62 Bn |
| Sep 30, 2021 | 3.79 Bn |
API Access
BioNTech SE Net Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income&ticker=BNTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income", "ticker": "BNTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income&ticker=BNTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();